SCHEMBL13696402

SCHEMBL13696402

CCCCOCC1O[C@@H](c2ccc(C=O)n2N)[C@](C)(OCCCC)[C@@H]1OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9912326 1.00 — —
SCHEMBL11924464 1.00 — —
SCHEMBL12389152 0.86 — —
SCHEMBL13696396 0.85 — —
SCHEMBL9912323 0.85 — —
SCHEMBL11924456 0.85 — —
SCHEMBL13392130 0.78 — —
SCHEMBL9912342 0.77 HIF1A (0.32) —
SCHEMBL13696397 0.77 HIF1A (0.32) —
SCHEMBL9912340 0.77 HIF1A (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227524-A1 ANTIVIRAL THERAPEUTIC AGENTS BIOCRYST PHARMACEUTICALS, INC. (US) 2009-09-10 — — US disclosed
Send feedback